Atara Biotherapeutics prospectus covers up to $200 million in securities
ATRA•Atara Biotherapeutics filed a base prospectus covering up to $200 million in securities and a sales agreement prospectus covering up to $23.01 million in common stock.
1. Prospectus offerings
Atara Biotherapeutics’ SEC filings cover an offering of up to $200 million in securities and an offering of up to $23.01 million in common stock under a sales agreement prospectus.
